IN BRIEF: GSK global supply chain director sells 38,000 shares
GSK PLC - London-based pharmaceuticals maker - Global Supply Chain President Regis Simard sells 38,000 shares at GBP20.38 each, for GBP774,440, on Wednesday in London. Read More
| Price | 1,931.50p on 31-07-2026 at 17:15:07 |
|---|---|
| Change | -8.50p -0.44% |
| Buy | 1,928.00p |
| Sell | 1,927.00p |
| Last Trade: | Sell 15,965.00 at 1,931.50p |
| Day's Volume: | 6,863,370 |
| Last Close: | 1,931.50p |
| Open: | 1,930.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,917.00p - 1,948.50p |
| 52wk Range: | 1,361.00p - 2,282.00p |
| Market Capitalisation: | £77.39b |
| VWAP: | 1,931.82692p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 15,965 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:15 - 31-Jul-26 |
| Sell* | 4,489 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:15 - 31-Jul-26 |
| Sell* | 1,164 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:14 - 31-Jul-26 |
| Sell* | 80,867 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:11 - 31-Jul-26 |
| Sell* | 14,491 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:11 - 31-Jul-26 |
| Sell* | 207 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:11 - 31-Jul-26 |
| Sell* | 18,250 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:11 - 31-Jul-26 |
| Sell* | 2,711 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:10 - 31-Jul-26 |
| Sell* | 2,412 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:10 - 31-Jul-26 |
| Sell* | 6,290 | 1,931.50p | SI Trade Suspected SELL Trade |
17:26:07 - 31-Jul-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Jul 2026 12:05 pm | RNS | New GSK flagship R&D centre in Cambridge |
| 28th Jul 2026 12:00 pm | RNS | 2nd Quarter Results |
| 28th Jul 2026 11:06 am | RNS | Hansoh positive 2nd Phase III results for Riz-Rez |
| 24th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jul 2026 3:00 pm | RNS | Admission to Trading |
| 22nd Jul 2026 5:22 pm | RNS | Jideytro approved in US for certain lung cancers |
| 20th Jul 2026 7:00 am | RNS | Bexsero 1-dose booster EMA file acceptance |
| 17th Jul 2026 12:00 pm | RNS | Audit tender conclusion |
| 17th Jul 2026 9:30 am | RNS | Camlipixant phase III results update |